Motley Fool Wealth Management LLC Sells 37,858 Shares of Inari Medical, Inc. (NASDAQ:NARI)

Motley Fool Wealth Management LLC trimmed its position in Inari Medical, Inc. (NASDAQ:NARI) by 17.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 174,360 shares of the company’s stock after selling 37,858 shares during the period. Motley Fool Wealth Management LLC owned 0.30% of Inari Medical worth $9,686,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Vestal Point Capital LP lifted its holdings in Inari Medical by 342.9% in the third quarter. Vestal Point Capital LP now owns 1,550,000 shares of the company’s stock valued at $63,922,000 after acquiring an additional 1,200,000 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Inari Medical during the 3rd quarter valued at $1,397,000. Verition Fund Management LLC purchased a new stake in shares of Inari Medical in the third quarter worth approximately $1,235,000. Jane Street Group LLC lifted its holdings in Inari Medical by 32.4% during the 3rd quarter. Jane Street Group LLC now owns 95,223 shares of the company’s stock valued at $3,927,000 after buying an additional 23,286 shares in the last quarter. Finally, Intech Investment Management LLC purchased a new position in shares of Inari Medical during the third quarter valued at $716,000. 90.98% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on NARI shares. Robert W. Baird restated a “neutral” rating and set a $80.00 price target (down previously from $81.00) on shares of Inari Medical in a research note on Tuesday, January 7th. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $80.00 price target (up from $74.00) on shares of Inari Medical in a research note on Tuesday, January 7th. Piper Sandler raised their target price on Inari Medical from $52.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Baird R W cut shares of Inari Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company reiterated an “equal weight” rating and issued a $80.00 price objective (up from $65.00) on shares of Inari Medical in a research note on Tuesday, January 7th. Twelve investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $68.00.

Insider Activity at Inari Medical

In related news, Director William Hoffman sold 200,000 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $60.47, for a total value of $12,094,000.00. Following the completion of the transaction, the director now directly owns 238,987 shares in the company, valued at approximately $14,451,543.89. The trade was a 45.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.60% of the stock is currently owned by company insiders.

Inari Medical Price Performance

Shares of NARI stock opened at $79.97 on Wednesday. Inari Medical, Inc. has a 12 month low of $36.73 and a 12 month high of $79.99. The firm has a market cap of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. The stock has a 50 day moving average of $79.84 and a 200-day moving average of $60.81.

Inari Medical Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.